Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)

China flag China · Delayed Price · Currency is CNY
23.71
-0.88 (-3.58%)
At close: Apr 29, 2026
15.85%
Market Cap 3.56B
Revenue (ttm) 520.97M
Net Income (ttm) 133.58M
Shares Out 150.34M
EPS (ttm) 0.88
PE Ratio 26.93
Forward PE n/a
Dividend 0.12 (0.47%)
Ex-Dividend Date May 20, 2025
Volume 3,610,548
Average Volume 5,873,151
Open 24.37
Previous Close 24.59
Day's Range 23.69 - 24.39
52-Week Range 19.33 - 28.00
Beta 0.38
RSI 42.09
Earnings Date Aug 14, 2026

About SHE:001367

Zhejiang Haisen Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical intermediates, active pharmaceutical ingredients, and preparations in China and internationally. The company offers active pharmaceutical ingredients for use as antilipemic agents, antipyretic analgesics, antidepressants, analgesics, antibacterial agents, histamine drugs, and anticonvulsants, as well as for anti-gastric ulcers, and digestive and cardiovascular applications. It also provides chemi... [Read more]

Sector Healthcare
Founded 1998
Employees 705
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 001367
Full Company Profile

Financial Performance

In 2025, SHE:001367's revenue was 532.26 million, an increase of 12.88% compared to the previous year's 471.51 million. Earnings were 135.88 million, an increase of 10.87%.

Financial Statements

News

There is no news available yet.